£595.00

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

2016-2021 US Over-The-Counter Generic Drugs Market Outlook

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £595 Days at Price

Price Analysis

Most common price: £595 (38 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 38 days

Description

This econometric study provides a comprehensive latent demand outlook for over-the-counter generic drugs across United States states and cities. The research delivers potential industry earnings (P.I.E.) estimates across approximately 12,700 cities, with each city's percentage share of its state and national market clearly calculated. Comparative benchmarks enable readers to assess city-level opportunities relative to peers, making this analysis invaluable for distribution planning and sales force strategy development. The statistical methodology supports data-driven decision-making for businesses operating in the OTC generic pharmaceutical sector, offering granular market intelligence at the municipal level to identify growth opportunities and competitive positioning within the broader US healthcare market.

Key Features

Covers latent demand outlook for over-the-counter generic drugs across 12,700 US cities with market size estimates in millions of dollars.

Provides potential industry earnings (P.I.E.) calculations for each city alongside percentage share comparisons to state and national markets.

Enables comparative benchmarking across cities to assess market opportunities and competitive positioning for distribution and sales strategies.

Uses econometric methodology to deliver statistical analysis supporting business planning in the OTC generic drug sector.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 September 2015
Listed Since
02 June 2016

Similar Products You Might Like

The 2016-2021 Outlook for Intranasal Drug Delivery Applications in the United States
93% match

The 2016-2021 Outlook for Intranasal Drug Delivery Applications in the United States

£595.00 27 Sep 2026
The 2016-2021 Outlook for Non-Prescription Cough and Cold Lozenges in the United States
93% match

The 2016-2021 Outlook for Non-Prescription Cough and Cold Lozenges in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Rubber Druggist and Medical Sundries Excluding Household Gloves in the United States
92% match

The 2016-2021 Outlook for Rubber Druggist and Medical Sundries Excluding Household Gloves in the United States

£595.00 28 Sep 2026
2016-2021 Vitamins Outlook United States - Market Demand Study
92% match

2016-2021 Vitamins Outlook United States - Market Demand Study

£595.00 28 Sep 2026
2016-2021 US Retail Sales Outlook - Economic Forecast Report
92% match

2016-2021 US Retail Sales Outlook - Economic Forecast Report

£595.00 28 Sep 2026
The 2016-2021 Outlook for Non-Store Retailing in the United States
92% match

The 2016-2021 Outlook for Non-Store Retailing in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Synthetic Antispasmodics and Anticholinergics Pharmaceutical Preparations in the United States
92% match

The 2016-2021 Outlook for Synthetic Antispasmodics and Anticholinergics Pharmaceutical Preparations in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Psoriasis Drugs in the United States
92% match

The 2016-2021 Outlook for Psoriasis Drugs in the United States

£595.00 27 Sep 2026
The 2016-2021 Outlook for First Aid Products in the United States
92% match

The 2016-2021 Outlook for First Aid Products in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Prescription Barbituate Anxiolytic and Hypnotic Sedatives in the United States
91% match

The 2016-2021 Outlook for Prescription Barbituate Anxiolytic and Hypnotic Sedatives in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Inflammatory Bowel Disease Therapeutics in the United States
91% match

The 2016-2021 Outlook for Inflammatory Bowel Disease Therapeutics in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Independent Grocers in the United States
91% match

The 2016-2021 Outlook for Independent Grocers in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Online Video Games in the United States
91% match

The 2016-2021 Outlook for Online Video Games in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Outsourcing Services in the United States
91% match

The 2016-2021 Outlook for Outsourcing Services in the United States

£595.00 27 Sep 2026
The 2016-2021 Outlook for Prescription Eyeglass Lenses in the United States
91% match

The 2016-2021 Outlook for Prescription Eyeglass Lenses in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Systemic Broad- And Medium-Spectrum Antibiotic Erythromycins in the United States
91% match

The 2016-2021 Outlook for Systemic Broad- And Medium-Spectrum Antibiotic Erythromycins in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Rauwolfia-Alkaloid Preparation and Rauwolfia-Diuretic Combination Hypotensive Pharmaceuticals in the United States
91% match

The 2016-2021 Outlook for Rauwolfia-Alkaloid Preparation and Rauwolfia-Diuretic Combination Hypotensive Pharmaceuticals in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Household Consumer Durables in the United States
91% match

The 2016-2021 Outlook for Household Consumer Durables in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Online Books in the United States
91% match

The 2016-2021 Outlook for Online Books in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Weight Loss Products in the United States
91% match

The 2016-2021 Outlook for Weight Loss Products in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Nicotine Lozenges in the United States
91% match

The 2016-2021 Outlook for Nicotine Lozenges in the United States

£595.00 28 Sep 2026
2016-2021 Outlook for Newsstands in United States
91% match

2016-2021 Outlook for Newsstands in United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Packaged Diet Food in the United States
91% match

The 2016-2021 Outlook for Packaged Diet Food in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Non-Food Retailers in the United States
91% match

The 2016-2021 Outlook for Non-Food Retailers in the United States

£595.00 28 Sep 2026